Adult Cystic Fibrosis Conference, 2023

Adult Cystic Fibrosis Conference, 2023

1-2 December 2023 | Milan, Italy | #ACFMilan2023

Pulmonary exacerbation rates after three years of Elexacaftor/Tezacaftor/Ivacaftor therapy in adults with cystic fibrosis and severe lung disease

Pulmonary exacerbation rates after three years of Elexacaftor/Tezacaftor/Ivacaftor therapy in adults with cystic fibrosis and severe lung disease